Immunocore Holdings Stock Investor Sentiment

IMCR Stock  USD 32.79  0.51  1.58%   
Slightly above 60% of all Immunocore Holdings' retail investors are looking to take a long position. The analysis of the overall investor sentiment regarding Immunocore Holdings suggests that some traders are interested. Immunocore Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Immunocore Holdings. Many technical investors use Immunocore Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

60

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Immunocore Holdings' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Immunocore Holdings.

Immunocore Historical Sentiment

Although Immunocore Holdings' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Immunocore, such as negative comments on social media and news outlets, may cause fear in the market and push Immunocore Holdings' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Immunocore.
  

Immunocore Holdings Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Immunocore Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Immunocore Holdings Historical Investor Sentiment

Investor biases related to Immunocore Holdings' public news can be used to forecast risks associated with an investment in Immunocore. The trend in average sentiment can be used to explain how an investor holding Immunocore can time the market purely based on public headlines and social activities around Immunocore Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunocore Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunocore Holdings and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Immunocore Holdings news discussions. The higher the estimate score, the more favorable the investor's outlook on Immunocore Holdings.
six days ago at finance.yahoo.com         
Immunocore Holdings plc This Small-Cap Stock Is Ready To Explode
Yahoo News
six days ago at insidermonkey.com         
Immunocore Holdings plc This Small-Cap Stock Is Ready To Explode
insidermonkey News
six days ago at zacks.com         
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
zacks News
over a week ago at finance.yahoo.com         
Is Immunocore Holdings plc the Best Immunotherapy Stock to Buy Now?
Yahoo News
over a week ago at insidermonkey.com         
Is Immunocore Holdings plc the Best Immunotherapy Stock to Buy Now?
insidermonkey News
over a week ago at zacks.com         
AbbVies Ovarian Cancer Drug Elahere Gets Approval in Europe
zacks News
over a week ago at gurufocus.com         
T. Rowe Price Investment Management, Inc. Expands Stake in Immunocore Holdings PLC
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
SpringWorks Q3 Loss Narrower Than Expected, Revenues Miss Mark
zacks News
over a week ago at investing.com         
Immunocores SWOT analysis biotech stock faces pivotal moment amid PRAME data
Investing News at Macroaxis
over two weeks ago at seekingalpha.com         
Immunocore cut to neutral by Mizuho over brenetafusp outlook
seekingalpha News
over two weeks ago at investing.com         
Mizuho downgrades Immunocore stock to Neutral, slashes PT to 38 from 72
Investing News at Macroaxis
over two weeks ago at simplywall.st         
Immunocore Holdings Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Fiera Capital Corp Cuts Position in Immunocore Holdings plc
news
over two weeks ago at zacks.com         
Wall Street Analysts Predict an 112.56 percent Upside in Immunocore Heres What You Should Know
zacks News
over two weeks ago at finance.yahoo.com         
Wall Street Analysts Predict an 112.56 percent Upside in Immunocore Heres What You Should Know
Yahoo News
Far too much social signal, news, headlines, and media speculation about Immunocore Holdings that are available to investors today. That information is available publicly through Immunocore media outlets and privately through word of mouth or via Immunocore internal channels. However, regardless of the origin, that massive amount of Immunocore data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunocore Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunocore Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunocore Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunocore Holdings alpha.

Immunocore Holdings Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 8676 shares by Herbst Roy Steven of Immunocore Holdings at 58.69 subject to Rule 16b-3
09/17/2024
2
Immunocore Investment Analysts Weekly Ratings Updates
09/18/2024
3
Immunocore Holdings plc Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
10/08/2024
4
ZIVO Bioscience versus Immunocore Head-To-Head Contrast
10/16/2024
5
Discretionary transaction by Baker Bros. Advisors Lp of 674261 shares of Immunocore Holdings subject to Rule 16b-3
10/25/2024
6
Analysts Set Immunocore Holdings plc Price Target at 79.82
10/29/2024
7
Immunocore Upgraded to Buy Heres Why
11/05/2024
8
Wellington Management Group LLPs Strategic Acquisition in Immunocore Holdings PLC
11/08/2024
9
Mizuho downgrades Immunocore stock to Neutral, slashes PT to 38 from 72
11/11/2024
10
T. Rowe Price Investment Management, Inc. Expands Stake in Immunocore Holdings PLC
11/14/2024
11
Is Immunocore Holdings plc the Best Immunotherapy Stock to Buy Now
11/18/2024
12
Immunocore Holdings plc This Small-Cap Stock Is Ready To Explode
11/19/2024

Additional Tools for Immunocore Stock Analysis

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.